|
Moghimi 2019 [20]
|
Iran
|
NA (n = 8)
|
NA (n = 62)
|
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59
|
Case-control
|
|
Yang 2016 [24]
|
China
|
NA (n = 64)
|
NA (n = 289)
|
18 HPV genotypes including 16,45,52,59,18,33,68,81
|
Cross-sectional
|
|
Garolla 2016 [21]
|
Italy
|
NA (n = 54)
|
NA (n = 172)
|
NA
|
Cross-sectional
|
|
Foresta 2015 [22]
|
Italy
|
37.1 ± 7.4 (n = 179)
|
38.2 ± 8.1 (n = 440)
|
6, 11, 16, 18, 26, 31, 33, 35, 39, 40,42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 66, 68, 69, 71, 70, 73, 74,
|
Cohort
|
|
Yang 2015 [25]
|
China
|
NA (n = 86)
|
NA (n = 41)
|
6,11,16,18,31,33,45,52,56,58
|
Cross-sectional
|
|
Zheng 2014 [26]
|
China
|
NA (n = 30)
|
NA (n = 300)
|
6,16,18,31,33,52,58
|
Cross-sectional
|
|
Foresta 2013 [23]
|
Italy
|
38.8 ± 9.8 (n = 16)
|
37.5 ± 5.9 (n = 16)
|
HPV-16
|
Cross-sectional
|
|
Yang 2013 [19]
|
China
|
NA (n = 107)
|
NA (n = 508)
|
At least 20 HPV genotypes, including 6, 11,16, 18, 31, 33,39, 40, 42, 43,45, 51, 52, 53,54, 59, 66, 68,70, 81
|
Cross-sectional
|
|
Garolla 2013 [17]
|
Italy
|
35.3 ± 4.7 (n = 61)
|
34.2 ± 3.8 (n = 104)
|
6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 66, 68, 69/71, 70, 73, 74, 82.
|
Cross-sectional
|
|
Foresta 2010 [18]
|
Italy
|
NA (n = 11)
|
NA (n = 97)
|
6,16,18,52,53,56,61,66,70,84,90
|
Cross-sectional
|
